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Abstract
To investigate an increased incidence of human cultures growing
Salmonella enterica ssp. diarizonae serotype 61:k:1,5,7 in France in
2008, we reviewed medical records of case patients and identi-
ﬁed the material used during invasive procedures and for bacte-
rial culture. Trace-back investigations incriminated culture media
containing contaminated sheep blood agar.
Keywords: Blood agar, contamination, pseudo-outbreak,
Salmonella enterica ssp. diarizonae
Original Submission: 7 June 2010; Revised Submission:
26 July 2010; Accepted: 27 July 2010
Editor: G. Pappas
Article published online: 12 August 2010
Clin Microbiol Infect 2011; 17: 915–918
10.1111/j.1469-0691.2010.03343.x
Corresponding author: J. M. Thiolet, Institut de Veille Sanitaire,
De´partement des Maladies Infectieuses, 12 rue du Val d’Osne,
94415 Saint-Maurice Ce´dex, France
E-mail: jm.thiolet@invs.sante.fr
Salmonella enterica ssp. diarizonae (SIIIb) is known to cause
infections in ectothermic animals [1], and SIIIb with the anti-
genic formula 61:k:1,5,7 has been found in sheep ﬂocks [2].
However, only a few human cases related to S. enterica ssp.
arizonae or SIIIb have been described [3,4]. In France, surveil-
lance of human salmonellosis is performed by the National
Reference Centre for Salmonella (NRC-Salm), which collects
isolates from one-third of all French medical laboratories.
From March to May 2008, the NRC-Salm received ten
isolates of SIIIb (antigenic formula 61:k:1,5,7 or its monopha-
sic variant 61:-:1,5,7) vs. ﬁve isolates during the two previous
years. All strains were susceptible to all antibiotics tested at
the NRC-Salm [5]. An investigation was initiated by the
French Institute for Public Health Surveillance with the Nos-
ocomial Infections Regional Coordinating Centres in order
to describe the cases, to ﬁnd a potential common source,
and to take appropriate control measures.
The attending physicians of patients were interviewed, and
medical records were reviewed. As case no. 1 was retro-
spectively identiﬁed, no investigation was conducted on this
case. The ten cases (cases no. 2 to no. 11) were inpatients
from ten different healthcare facilities located in seven
regions (Table 1). None of the patients had digestive symp-
toms suggestive of Salmonella infection, but one had under-
gone a 3-week course of antibiotics because of this SIIIb
isolation. All samples had been taken during routine screen-
ing. SIIIb was isolated from different body sites, including nine
from usually sterile sites. No common procedure or com-
mon material was identiﬁed. The unusual clinical presentation
and unusual serotype of Salmonella led to the suspicion that
the origin of the contamination might be linked to the labo-
ratory processing of the samples. Thorough investigations
revealed that nine of the ten isolates had grown on sheep
blood agar from the same manufacturer and that the batch
number was similar for three cases. Moreover, SIIIb
61:k:1,5,7 infections in European sheep ﬂocks had previously
been described [6].
The manufacturer, interviewed by the French Health
Products Safety Agency, indicated that several samples of
agar had been found to be positive for SIIIb 61:k:1,5,7 in
2004, owing to contaminated sheep blood from the ﬂock of
its blood provider. In order to reduce the risk of agar con-
tamination, the manufacturer modiﬁed the procedures for
procurement of blood (strict immobilization of the sheep’s
head during the process, reinforcement of injection site dis-
infection, and improvement of hygiene in the operating
room). Additionally, in 2008, it had received ﬁve complaints
from laboratories concerning the batch used for the cultures
of three of our cases. In June 2008, the manufacturer rein-
forced its quality control procedures, implementing blood
culture for each animal (samples were previously pooled). It
informed its customers, in France and abroad, in order to
avoid the reporting of a false-positive result.
From July 2008 to June 2009, the NRC-Salm received
two additional human SIIIb strains (cases no. 12 and
no. 13), and SIIIb strains isolated from blood agar of the
manufacturer and from sheep blood from the ﬂock of its
blood provider.
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The genetic diversity of SIIIb isolates was assessed by Pulse-
Net (http://pulsenetinternational.org) standardized pulsed-
ﬁeld gel electrophoresis (PFGE) analysis of XbaI-digested
chromosomal DNA (Fig. 1). All but one of the human isolates
collected between 2005 and 2009 by the NRC-Salm were
tested (n = 21). They had been isolated from stool samples
from sporadic cases (n = 8) or from other sites (n = 13), the
latter all being related to the pseudo-outbreak. Fourteen non-
human isolates, including 13 from sheep blood agar, pooled
sheep blood, and blood cultures from individual sheep of the
manufacturer’s herd, were also tested. Two comparison
strains, one of human origin isolated in 1976 and the refer-
ence strain Minn 240/66, were also included. Seventeen differ-
ent PFGE proﬁles were obtained. Unexpectedly, among the
13 isolates from the pseudo-outbreak cases, six different pro-
ﬁles were seen. However, these proﬁles were also seen
among the 13 non-human isolates. All proﬁles seen in human
stool isolates were different and distinct from those seen in
pseudo-outbreak cases and sheep blood cultures. The PFGE
analysis of the two oldest sheep blood isolates from the blood
provider showed proﬁle X6 (data not shown).
Our investigation demonstrated that this particular SIIIb
serotype circulating among sheep was responsible for blood
agar contamination that led to false-positive results in clinical
microbiology laboratories, resulting in a pseudo-outbreak of
salmonellosis at a national level. To the best of our knowl-
edge, this is the ﬁrst report of a multisite pseudo-outbreak
with an identiﬁed source. Other pseudo-outbreaks of bacte-
rial infections have been described previously; however, they
were limited to a single healthcare facility, and a local expla-
nation was found [7–9].
Among these SIIIb pseudo-cases, one had undergone
unnecessary antibiotic treatment for 3 weeks. For some
other cases, the attending physician did not take into account
the result of the specimen culture. For the others, the micro-
biologist considered the sample to be contaminated. This
emphasizes the need for caution, by both microbiologists and
physicians, when interpreting culture results.
The ﬁrst isolate related to this pseudo-outbreak had been
sent to the NRC-Salm in December 2007, although the man-
ufacturer had been aware of the ﬂock contamination since
2004 [10]. The quality control procedures of the agar manu-
facturer may have been relatively efﬁcient, or the number of
contaminated batches may have been rather low. However,
it is probable that not all SIIIb isolates have been received at
the NRC-Salm, because its network does not cover all labo-
ratories, and because laboratories did not report all of them.
Indeed, the interpretation of bacteriological culture results
may depend on the origin of the sample, the contamination
rate of blood agar, and the experience of the laboratory
technician.
This likely underestimation of the cases by the laboratory-
based surveillance underlines the need for better reporting
to the health products vigilance system by both agar manu-
facturers and microbiologists. The French Health Products
Safety Agency decided against a sheep blood agar recall,
because of the implementation of control measures by the
manufacturer, and because of the risk of a nationwide short-
age of media for bacteriological diagnosis.
The PFGE subtyping method was very discriminative for
this serotype, as reported previously in Norwegian and
Swedish sheep [6].
In conclusion, we have demonstrated that the rare SIIIb
serotype 61:k:1,5,7 or its monophasic variant 61:-:1,5,7 con-
sidered to be adapted to sheep, may cause sheep blood agar
contamination and lead to false-positive culture results and to
pseudo-outbreaks. This knowledge could be useful for
microbiologists, physicians and epidemiologists. Furthermore,
we have shown by PFGE that different strains of this serotype
are circulating among sheep and might consequently be recov-
ered during a single pseudo-outbreak. This is of importance
in countries using real-time PFGE subtyping surveillance.
TABLE 1. Pseudo-cases of Salmonella enterica ssp. diarizonae serotypes 61:k:1,5,7 and 61:-:1,5,7, France, 2007–2009
Case no. Region of France Age range (years) Month of isolation Isolation site Serotype PFGE proﬁle
1 Bourgogne 70–80 December 2007 Knee joint 61:-:1,5,7 X6
2 Ile-de-France 50–60 January 2008 Knee joint 61:-:1,5,7 X6
3 Ile-de-France 70–80 January 2008 Arterial catheter 61:-:1,5,7 X7
4 Aquitaine 50–60 January 2008 Mediastinal biopsy 61:-:1,5,7 X7
5 Aquitaine 60–70 February 2008 Abdominal wall haematoma 61:k:1,5,7 X8
6 Poitou-Charentes 50–60 March 2008 Central venous catheter 61:-:1,5,7 X10
7 Midi-Pyrenees 20–30 April 2008 Pleural ﬂuid 61:-:1,5,7 X9
8 Lorraine 50–60 May 2008 Bronchial expectoration 61:-:1,5,7 X10
9 Pays-de-la-Loire Newborn May 2008 Gastric ﬂuid 61:k:1,5,7 X10
10 Ile-de France 50–60 May 2008 Skin lesion 61:-:1,5,7 X10
11 Rhoˆne-Alpes Newborn April 2008 Umbilical catheter 61:-:1,5,7 X10
12 Ile-de France 1–10 October 2008 Knee joint 61:-:1,5,7 X12
13 Ile-de France 50–60 May 2009 Bronchial expectoration 61:k:1,5,7 X9
PFGE, pulsed-ﬁeld gel electrophoresis.
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Abstract
Bartonella (B.) henselae is the zoonotic agent of cat scratch dis-
ease. B. henselae has been associated with therapy-resistant
Lyme disease in humans suggesting that B. henselae and Borrelia
burgdorferi sensu lato might be transmitted concurrently by ticks.
In the present study we found that 16 (6.9%) of 230 Ixodes rici-
nus collected from humans harboured DNA of Bartonella spp.
Fifteen positive ticks were infected with B. henselae and one tick
with B. clarridgeiae. Twenty-ﬁve percent of the 16 Bartonella posi-
tive ticks were co-infected with Borrelia burgdorferi sensu lato.
Our data show that B. henselae is present in Ixodes ricinus and
that ticks may serve as source of infection for humans.
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Members of the genus Bartonella are small, fastidious Gram-
negative rod-shaped bacteria.
They are emerging arthropod-borne pathogens that can
cause severe disease in humans and animals [1,2]. B. henselae
is the causative agent of cat scratch disease, characterized by
clinical symptoms with varying severity [3]. B. henselae is
found in cats, and cat ﬂeas are well established vectors for
B. henselae transmission among cats [4]. Infection of humans
seems to occur via cat scratches or bites, however, transmis-
sion by other arthropods, in particular ticks, is suggested
[5,6].
Ticks are known to transmit a large spectrum of emerging
bacterial zoonotic pathogens [7] including Borrelia burgdorferi
sensu lato (sl) [8], Anaplasma phagocytophilum [9], and Babesia
spp. [10]. B. henselae DNA was detected in Ixodes (I.) paciﬁ-
cus and I. persulcatus ticks in North America, Eastern Europe,
and Russia [11–15]. Furthermore, in I. scapularis, co-infection
with Bartonella spp. and Borrelia burgdorferi sl has been
described [16]. I. ricinus is the most widespread and abundant
ixodid tick in Western Europe feeding on humans or domes-
tic animals [17–19]. More recently it was shown that
B. henselae persists during the developmental stages of I. rici-
nus ticks and that inoculation of cats with salivary glands of
these ticks resulted in B. henselae bacteremia. These results
strongly indicate a putative transmission of B. henselae to
mammals by ticks [20].
The impact of this vector bound transmission of B. hense-
lae on humans is still unknown. Evidence for tick transmis-
sion of Bartonella is supported by the study of Angelakis et al.
(2008) [21] who identiﬁed B. henselae in tissues samples from
patients with a syndrome characterized by scalp eschar and
lymphadenopathy in close temporal sequence to a tick bite.
Moreover, B. henselae has been detected in I. ricinus ticks
collected from humans in Italy [19].
Interestingly, Eskow et al. (2001) related cases with ongo-
ing symptoms of chronic Lyme disease, in which B. henselae
and Borrelia burgdorferi sl were simultaneously detected, to
tick contact of the patients. They concluded that a concomi-
tant B. henselae infection might be the reason for unrespon-
siveness to standard therapy [22].
More recently it was shown that the prevalence of
B. henselae and Borrelia burgdorferi sl DNA in the environmen-
tal I. ricinus populations sampled in different European sites
was up to 40%. However, ticks co-infected with B. henselae
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